Autopsy report · NCT06735079
A Study to Evaluate the Efficacy and Safety of REL-1017 As Adjunctive Treatment of Major Depressive Disorder (MDD)
Cause of deathFunding or business, also slow enrollment
“The study was withdrawn based on business-related matters and there are no new safety concerns related to the trial. No patients were enrolled.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 3
- Sponsor
- MGGM LLC
- Sponsor type
- Industry
- Conditions
- Major Depressive Disorder (MDD)
- Interventions
- REL1017 (esmethadone HCI) (active drug); Placebo
- Participants
- 0
- Sites
- 2
- Countries
- Italy, Switzerland
Trials that died the same way
- Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer
“This study was withdrawn due to a strategic business decision; no patients were enrolled.” - A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients
“The study has been early terminated due to business reasons. This decision is not related to any safety, efficacy, or regulatory concerns.” - A Study Of PF-06664178 In Patients With Advanced Solid Tumors
“The study was prematurely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.” - Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke
“study was stopped for business/administrative reasons and not for patient safety concerns” - Long-Term Follow-up Study of Subjects With Fabry Disease Who Received Lentiviral Gene Therapy in Study AVRO-RD-01-201
“This study was voluntarily terminated due to a business decision not to proceed, and not due to any safety or efficacy issue.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.